Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash from Investing Activities (2016 - 2025)

CorMedix (CRMD) has disclosed Cash from Investing Activities for 12 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 1185.0% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$308.4 million through Dec 2025, down 1552.73% year-over-year, with the annual reading at -$308.4 million for FY2025, 1552.73% down from the prior year.
  • Cash from Investing Activities hit $3.3 million in Q4 2025 for CorMedix, up from -$291.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $8.9 million in Q1 2024 to a low of -$291.3 million in Q3 2025.
  • Historically, Cash from Investing Activities has averaged -$18.5 million across 5 years, with a median of -$208275.0 in 2021.
  • Biggest YoY gain for Cash from Investing Activities was 1185.0% in 2025; the steepest drop was 4708.5% in 2025.
  • Year by year, Cash from Investing Activities stood at -$7.1 million in 2021, then surged by 99.97% to -$1861.0 in 2022, then crashed by 789088.88% to -$14.7 million in 2023, then skyrocketed by 97.93% to -$303874.0 in 2024, then soared by 1185.0% to $3.3 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CRMD at $3.3 million in Q4 2025, -$291.3 million in Q3 2025, and -$20.2 million in Q2 2025.